Bourguignon L - Search Results

1

Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex difference.

Garreau R, Bricca R, Gagnieu MC, Roux S, Conrad A, Bourguignon L, Ferry T, Goutelle S; Lyon Bone and Joint Infection Study Group. Garreau R, et al. Among authors: bourguignon l. J Antimicrob Chemother. 2021 Apr 13;76(5):1250-1257. doi: 10.1093/jac/dkab006. J Antimicrob Chemother. 2021. PMID: 33550409

2

[Interindividual pharmacokinetic variability in long-term antibiotherapy].

Bourguignon L, Goutelle S, de Saint Martin JB, Guillermet A, Bouniot P, Maire P, Ducher M. Bourguignon L, et al. Med Mal Infect. 2010 Jan;40(1):38-41. doi: 10.1016/j.medmal.2009.03.003. Epub 2009 Apr 5. Med Mal Infect. 2010. PMID: 19346086 French.

3

Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs.

Goutelle S, Bourguignon L, Maire PH, Van Guilder M, Conte JE Jr, Jelliffe RW. Goutelle S, et al. Among authors: bourguignon l. Antimicrob Agents Chemother. 2009 Jul;53(7):2974-81. doi: 10.1128/AAC.01520-08. Epub 2009 Apr 20. Antimicrob Agents Chemother. 2009. PMID: 19380594 Free PMC article.

4

Visual estimation of patients' body weight in hospital: the more observers, the better?

Goutelle S, Bourguignon L, Bertrand-Passeron N, Jelliffe RW, Maire P. Goutelle S, et al. Among authors: bourguignon l. Pharm World Sci. 2009 Aug;31(4):422-425. doi: 10.1007/s11096-009-9295-y. Epub 2009 Apr 22. Pharm World Sci. 2009. PMID: 19387861

5

[Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight].

Bourguignon L, Goutelle S, Gérard C, Guillermet A, Burdin de Saint Martin J, Maire P, Ducher M. Bourguignon L, et al. Therapie. 2009 Jan-Feb;64(1):47-53. doi: 10.2515/therapie/2009009. Epub 2009 May 26. Therapie. 2009. PMID: 19463252 French.

6

Comment: modification of diet in renal disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.

Goutelle S, Bourguignon L, Ducher M, Maire P. Goutelle S, et al. Among authors: bourguignon l. Ann Pharmacother. 2009 Jun;43(6):1145-6; author reply 1146. doi: 10.1345/aph.1L144a. Epub 2009 Jun 2. Ann Pharmacother. 2009. PMID: 19491321 No abstract available.

7

Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study.

Bourguignon L, Goutelle S, De Saint-Martin JB, Maire P, Ducher M. Bourguignon L, et al. Fundam Clin Pharmacol. 2010 Feb;24(1):109-13. doi: 10.1111/j.1472-8206.2009.00732.x. Epub 2009 Sep 4. Fundam Clin Pharmacol. 2010. PMID: 19735306

8

Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin.

Goutelle S, Bourguignon L, Jelliffe RW, Conte JE Jr, Maire P. Goutelle S, et al. Among authors: bourguignon l. J Theor Biol. 2011 Aug 7;282(1):80-92. doi: 10.1016/j.jtbi.2011.05.013. Epub 2011 May 18. J Theor Biol. 2011. PMID: 21605569

9

Genotype-based quantitative prediction of drug exposure for drugs metabolized by CYP2D6.

Tod M, Goutelle S, Gagnieu MC; Genophar II Working Group. Tod M, et al. Clin Pharmacol Ther. 2011 Oct;90(4):582-7. doi: 10.1038/clpt.2011.147. Epub 2011 Aug 24. Clin Pharmacol Ther. 2011. PMID: 21866098

10

The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study.

Bourguignon L, Ducher M, Matanza D, Bleyzac N, Uhart M, Odouard E, Maire P, Goutelle S. Bourguignon L, et al. Fundam Clin Pharmacol. 2012 Apr;26(2):279-85. doi: 10.1111/j.1472-8206.2011.01000.x. Epub 2011 Oct 17. Fundam Clin Pharmacol. 2012. PMID: 22004557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page